Icomb 5 Mg/10 Mg Capsule Rigide

Ramipril and Amlodipine besilate, the active ingredients in Icomb 5 Mg/10 Mg Capsule Rigide, are an ACE inhibitor and a calcium channel blocker presented as a 5 mg/10 mg rigid capsule for oral use. They treat hypertension in adult patients, often as part of combination therapy to achieve target blood pressure.

GNH USA supplies Icomb 5 Mg/10 Mg Capsule Rigide as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Icomb combines ramipril and amlodipine to act on the renin‑angiotensin system and vascular calcium channels for the management of hypertension.

- Essential hypertension: lowers systolic and diastolic blood pressure to achieve guideline‑recommended targets. - High blood pressure: provides sustained blood pressure control when monotherapy is insufficient. - Hypertension requiring combination therapy: offers a fixed‑dose option that simplifies dosing and improves adherence.

The combination may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects: - Cough: dry, persistent cough. - Dizziness or light‑headedness: especially after standing. - Headache: mild to moderate intensity. - Peripheral edema: swelling of ankles or feet.

Serious or Rare Side Effects: - Angioedema: swelling of face, lips, tongue, or airway. - Severe hypotension: marked drop in blood pressure causing fainting. - Liver enzyme elevation: increased ALT or AST levels. - Neutropenia: reduced white blood cell count.

Before prescribing Icomb, clinicians should consider several safety precautions.

- Monitor renal function: assess serum creatinine and eGFR periodically. - Check electrolytes: especially potassium levels to avoid hyperkalaemia. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Use caution in elderly: start at lower doses and monitor for orthostatic hypotension. - Pregnancy and lactation: safety not established; avoid unless benefits outweigh risks. - Store at ambient temperature below 25 °C: keep in original container, protect from moisture and light.

Icomb may interact with other medicines, influencing its efficacy or safety.

Major Interactions (Avoid): - Potassium‑sparing diuretics or supplements: increase risk of hyperkalaemia. - Concurrent use of another ACE inhibitor or ARB: additive renal impairment risk. - Lithium therapy: may raise lithium concentrations and toxicity.

Moderate Interactions (Monitor Closely): - NSAIDs (e.g., ibuprofen, naproxen): can blunt antihypertensive effect. - Strong CYP3A4 inhibitors (e.g., erythromycin, clarithromycin): raise amlodipine levels, increasing hypotension risk. - Thiazide or loop diuretics: may enhance blood‑pressure‑lowering effect, requiring dose adjustment.